DCF — CALIFORNIA PACIFIC MEDICAL CENTER
Enterprise Value: $-2.7B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-2.7B
Enterprise Value
$-842.2M
PV of Cash Flows
$-1.9B
PV of Terminal Value
$-3.0B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.0B | $-183.2M | -18.0% | $-226.3M | $-205.7M |
| Year 2 | $1.0B | $-178.2M | -17.0% | $-222.6M | $-183.9M |
| Year 3 | $1.1B | $-172.8M | -16.0% | $-218.4M | $-164.1M |
| Year 4 | $1.1B | $-172.4M | -16.0% | $-219.4M | $-149.9M |
| Year 5 | $1.1B | $-174.7M | -15.0% | $-223.2M | $-138.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-2.7B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$987.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.18504528430060016
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5